Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Unusual complication of an organophosphate poisoning.
Tafur AJ, Gonzalez L, Idrovo LA, Tafur A. Tafur AJ, et al. Among authors: tafur a. Emerg Med J. 2005 Jul;22(7):531. Emerg Med J. 2005. PMID: 15983103 Free PMC article. No abstract available.
The prognostic value of blood cellular indices in pulmonary embolism.
Siddiqui F, Tafur A, Hussain M, García-Ortega A, Darki A, Fareed J, Jiménez D, Bikdeli B, Galeano-Valle F, Fernández-Reyes JL, Pérez-Pinar M, Monreal M; RIETE Investigators. Siddiqui F, et al. Among authors: tafur a. Am J Hematol. 2024 Sep;99(9):1704-1711. doi: 10.1002/ajh.27379. Epub 2024 May 30. Am J Hematol. 2024. PMID: 38816957
A Call to Leadership: New VTE Treatment and Prevention Guidelines.
Esponda OL, Tafur AJ. Esponda OL, et al. Among authors: tafur aj. Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241243079. doi: 10.1177/10760296241243079. Clin Appl Thromb Hemost. 2024. PMID: 38562020 Free PMC article. No abstract available.
Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trial.
McBane RD 2nd, Loprinzi CL, Zemla T, Tafur A, Sanfilippo K, Liu JJ, Garcia DA, Heun J, Gundabolu K, Onitilo AA, Perepu U, Drescher MR, Henkin S, Houghton D, Ashrani A, Billett H, McCue SA, Lee MK, Le-Rademacher JG, Wysokinski WE; EVE trial investigators. McBane RD 2nd, et al. Among authors: tafur a. J Thromb Haemost. 2024 Jun;22(6):1704-1714. doi: 10.1016/j.jtha.2024.03.011. Epub 2024 Mar 25. J Thromb Haemost. 2024. PMID: 38537780 Clinical Trial.
Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper.
Harenberg J, Gosselin RC, Cuker A, Becattini C, Pabinger I, Poli S, Weitz J, Ageno W, Bauersachs R, Celap I, Choi P, Douketis J, Douxfils J, Elalamy I, Falanga A, Fareed J, Favaloro EJ, Gerotziafas G, Herkner H, Hetjens S, Heubner L, Klamroth R, Langer F, Lip GYH, Grory BM, Margetić S, Merrelaar A, Pikta M, Renne T, Schulman S, Schwameis M, Strbian D, Tafur A, Vassart J, Violi F, Walenga J, Weiss C. Harenberg J, et al. Among authors: tafur a. Thromb Haemost. 2024 Aug;124(8):770-777. doi: 10.1055/a-2261-1811. Epub 2024 Feb 5. Thromb Haemost. 2024. PMID: 38316416 Free article.
Temporal trends and outcomes of patients with chronic limb-threatening ischemia with and without history of coronary artery disease: insights from the us national inpatient sample database.
Chunawala ZS, Chew C, Hendrickson M, Arora S, Tafur A, Mishkel G, Ricciardi MJ, Zelniker TA, Moussa ID, Hassan A, Golzar J, Gueyikian S, Bechara CF, Lee CJ, Qamar A. Chunawala ZS, et al. Among authors: tafur a. J Invasive Cardiol. 2023 Oct;35(10). doi: 10.25270/jic/23.00191. J Invasive Cardiol. 2023. PMID: 37984325 Free article.
Defining heparin resistance: communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis.
Levy JH, Sniecinski RM, Rocca B, Ghadimi K, Douketis J, Frere C, Helms J, Iba T, Koster A, Lech TK, Maier CL, Neal MD, Scarlestscu E, Spyropoulos A, Steiner ME, Tafur AJ, Tanaka KA, Connors JM. Levy JH, et al. Among authors: tafur aj. J Thromb Haemost. 2023 Dec;21(12):3649-3657. doi: 10.1016/j.jtha.2023.08.013. Epub 2023 Aug 22. J Thromb Haemost. 2023. PMID: 37619694 Free article.
Cost-effectiveness analysis of extended thromboprophylaxis with rivaroxaban versus no prophylaxis in high-risk patients after hospitalisation for COVID-19: an economic modelling study.
Carvalho de Oliveira CC, Agati LB, Ribeiro CM, Resende Aguiar VC, Caffaro RA, da Silva Santos M, Alves Fernandes RR, Alberto da Silva Magliano C, Tafur A, Spyropoulos AC, Lopes RD, Fareed J, Ramacciotti E. Carvalho de Oliveira CC, et al. Among authors: tafur a. Lancet Reg Health Am. 2023 Aug;24:100543. doi: 10.1016/j.lana.2023.100543. Epub 2023 Jun 23. Lancet Reg Health Am. 2023. PMID: 37366432 Free PMC article.
Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer: A Randomized Clinical Trial.
Schrag D, Uno H, Rosovsky R, Rutherford C, Sanfilippo K, Villano JL, Drescher M, Jayaram N, Holmes C, Feldman L, Zattra O, Farrar-Muir H, Cronin C, Basch E, Weiss A, Connors JM; CANVAS Investigators. Schrag D, et al. JAMA. 2023 Jun 13;329(22):1924-1933. doi: 10.1001/jama.2023.7843. JAMA. 2023. PMID: 37266947 Free PMC article. Clinical Trial.
Differential Neutralization of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban by Andexanet Alfa as Measured by Whole Blood Thromboelastographic Analysis.
Mehrotra S, Hoppensteadt D, Jeske W, Siddiqui F, Iqbal O, Tafur A, Lewis B, Jaradeh M, Kantarcioglu B, Fareed J. Mehrotra S, et al. Among authors: tafur a. Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221138297. doi: 10.1177/10760296221138297. Clin Appl Thromb Hemost. 2022. PMID: 36476125 Free PMC article.
Cellular Indices and Outcome in Patients with Acute Venous Thromboembolism.
Siddiqui F, García-Ortega A, Kantarcioglu B, Sinacore J, Tafur A, Demelo-Rodríguez P, Antonio Nieto J, Usandizaga E, Fareed J, Monreal M, The Riete Investigators. Siddiqui F, et al. Among authors: tafur a. Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221113346. doi: 10.1177/10760296221113346. Clin Appl Thromb Hemost. 2022. PMID: 35866197 Free PMC article.
A Prospective Study Evaluating Patterns of Responses to the Caprini Score to Prevent Venous Thromboembolism After Interventional Treatment for Varicose Veins.
Grill MH, Caffaro RA, Grill TA, Júnior VC, Kikuchi R, Ribeiro CM, da Silva VS, Tafur AJ, Caprini JA, Ramacciotti E. Grill MH, et al. Among authors: tafur aj. Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221112081. doi: 10.1177/10760296221112081. Clin Appl Thromb Hemost. 2022. PMID: 35850592 Free PMC article.
Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial.
Ramacciotti E, Barile Agati L, Calderaro D, Aguiar VCR, Spyropoulos AC, de Oliveira CCC, Lins Dos Santos J, Volpiani GG, Sobreira ML, Joviliano EE, Bohatch Júnior MS, da Fonseca BAL, Ribeiro MS, Dusilek C, Itinose K, Sanches SMV, de Almeida Araujo Ramos K, de Moraes NF, Tierno PFGMM, de Oliveira ALML, Tachibana A, Chate RC, Santos MVB, de Menezes Cavalcante BB, Moreira RCR, Chang C, Tafur A, Fareed J, Lopes RD; MICHELLE investigators. Ramacciotti E, et al. Among authors: tafur a. Lancet. 2022 Jan 1;399(10319):50-59. doi: 10.1016/S0140-6736(21)02392-8. Epub 2021 Dec 15. Lancet. 2022. PMID: 34921756 Free PMC article. Clinical Trial.
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.
Spyropoulos AC, Goldin M, Giannis D, Diab W, Wang J, Khanijo S, Mignatti A, Gianos E, Cohen M, Sharifova G, Lund JM, Tafur A, Lewis PA, Cohoon KP, Rahman H, Sison CP, Lesser ML, Ochani K, Agrawal N, Hsia J, Anderson VE, Bonaca M, Halperin JL, Weitz JI; HEP-COVID Investigators. Spyropoulos AC, et al. Among authors: tafur a. JAMA Intern Med. 2021 Dec 1;181(12):1612-1620. doi: 10.1001/jamainternmed.2021.6203. JAMA Intern Med. 2021. PMID: 34617959 Free PMC article. Clinical Trial.
Medically Ill hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis with rivaroxaban ThErapy: Rationale and Design of the MICHELLE Trial.
Ramacciotti E, Agati LB, Calderaro D, Volpiani GG, de Oliveira CCC, Aguiar VCR, Rodrigues E, Sobreira ML, Joviliano EE, Dusilek C, Itinose K, Dedivitis RA, Cortina AS, Sanches SMV, de Moraes NF, Tierno PFGMM, de Oliveira ALML, Tachibana A, Chate RC, Santos MVB, Cavalcante BBM, Moreira RCR, Chiann C, Tafur A, Spyropoulos AC, Lopes RD. Ramacciotti E, et al. Among authors: tafur a. Am Heart J. 2021 Dec;242:115-122. doi: 10.1016/j.ahj.2021.08.016. Epub 2021 Sep 1. Am Heart J. 2021. PMID: 34480880 Free PMC article.
Association Between Preexisting Versus Newly Identified Atrial Fibrillation and Outcomes of Patients With Acute Pulmonary Embolism.
Bikdeli B, Jiménez D, Del Toro J, Piazza G, Rivas A, Fernández-Reyes JL, Sampériz Á, Otero R, Suriñach JM, Siniscalchi C, Martín-Guerra JM, Castro J, Muriel A, Lip GYH, Goldhaber SZ, Monreal M; RIETE Investigators †. Bikdeli B, et al. J Am Heart Assoc. 2021 Sep 7;10(17):e021467. doi: 10.1161/JAHA.121.021467. Epub 2021 Aug 28. J Am Heart Assoc. 2021. PMID: 34459215 Free PMC article.
Direct Oral Anticoagulants Compared With Dalteparin for Treatment of Cancer-Associated Thrombosis: A Living, Interactive Systematic Review and Network Meta-analysis.
Riaz IB, Fuentes HE, Naqvi SAA, He H, Sipra QR, Tafur AJ, Padranos L, Wysokinski WE, Marshall AL, Vandvik PO, Montori V, Bryce AH, Liu H, Badgett RG, Murad MH, McBane RD 2nd. Riaz IB, et al. Mayo Clin Proc. 2022 Feb;97(2):308-324. doi: 10.1016/j.mayocp.2020.10.041. Epub 2021 Jun 22. Mayo Clin Proc. 2022. PMID: 34172290
The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper.
Gerotziafas GT, Catalano M, Theodorou Y, Dreden PV, Marechal V, Spyropoulos AC, Carter C, Jabeen N, Harenberg J, Elalamy I, Falanga A, Fareed J, Agathaggelou P, Antic D, Antignani PL, Bosch MM, Brenner B, Chekhonin V, Colgan MP, Dimopoulos MA, Douketis J, Elnazar EA, Farkas K, Fazeli B, Fowkes G, Gu Y, Gligorov J, Ligocki MA, Indran T, Kannan M, Kantarcioglu B, Kasse AA, Konstantinidis K, Leivano F, Lewis J, Makatsariya A, Mbaye PM, Mahé I, Panovska-Stavridis I, Olinic DM, Papageorgiou C, Pecsvarady Z, Pillon S, Ramacciotti E, Abdel-Razeq H, Sabbah M, Sassi M, Schernthaner G, Siddiqui F, Shiomura J, Slama-Schwok A, Wautrecht JC, Tafur A, Taher A, Klein-Wegel P, Zhai Z, Zoubida TM; Scientific Reviewer Committee. Gerotziafas GT, et al. Among authors: tafur a. Thromb Haemost. 2021 Aug;121(8):992-1007. doi: 10.1055/a-1535-8807. Epub 2021 Jul 20. Thromb Haemost. 2021. PMID: 34169495 Free PMC article.
An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination.
Kantarcioglu B, Iqbal O, Walenga JM, Lewis B, Lewis J, Carter CA, Singh M, Lievano F, Tafur A, Ramacciotti E, Gerotziafas GT, Jeske W, Fareed J. Kantarcioglu B, et al. Among authors: tafur a. Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211021498. doi: 10.1177/10760296211021498. Clin Appl Thromb Hemost. 2021. PMID: 34060379 Free PMC article. Review.
Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID Trial.
Goldin M, Giannis D, Diab W, Wang J, Khanijo S, Sharifova G, Cohen M, Lund JM, Mignatti A, Gianos E, Tafur A, Lewis PA, Cohoon K, Kittelson JM, Lesser ML, Sison CP, Rahman H, Ochani K, Hiatt WR, Dale RA, Anderson VE, Bonaca M, Halperin JL, Weitz JI, Spyropoulos AC. Goldin M, et al. Among authors: tafur a. Thromb Haemost. 2021 Dec;121(12):1684-1695. doi: 10.1055/a-1475-2351. Epub 2021 May 28. Thromb Haemost. 2021. PMID: 33823560
Timing and characteristics of venous thromboembolism after noncancer surgery.
Expósito-Ruiz M, Arcelus JI, Caprini JA, López-Espada C, Bura-Riviere A, Amado C, Loring M, Mastroiacovo D, Monreal M; RIETE Investigators. Expósito-Ruiz M, et al. J Vasc Surg Venous Lymphat Disord. 2021 Jul;9(4):859-867.e2. doi: 10.1016/j.jvsv.2020.11.017. Epub 2020 Nov 26. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 33248295
Presenting Characteristics, Treatment Patterns, and Outcomes among Patients with Venous Thromboembolism during Hospitalization for COVID-19.
Fernández-Capitán C, Barba R, Díaz-Pedroche MDC, Sigüenza P, Demelo-Rodriguez P, Siniscalchi C, Pedrajas JM, Farfán-Sedano AI, Olivera PE, Gómez-Cuervo C, Llamas P, Villares P, Sanchez O, López-Reyes R, Catella J, Bikdeli B, Weinberg I, Tafur AJ, Jiménez D, Monreal M. Fernández-Capitán C, et al. Semin Thromb Hemost. 2021 Jun;47(4):351-361. doi: 10.1055/s-0040-1718402. Epub 2020 Oct 21. Semin Thromb Hemost. 2021. PMID: 33086403 Clinical Trial.
National Physician Survey for Nonvalvular Atrial Fibrillation (NVAF) Anticoagulation Comparing Knowledge, Attitudes and Practice of Cardiologist to PCPs.
Saeed H, Ovalle OG, Bokhary U, Jermihov A, Lepkowska K, Bauer V, Kuchta K, Wright M, Glosner S, Frazer M, Quintero A, Hlavacek P, Mardekian J, Tafur A, Metzl M, Saucedo J. Saeed H, et al. Among authors: tafur a. Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620952550. doi: 10.1177/1076029620952550. Clin Appl Thromb Hemost. 2020. PMID: 33079570 Free PMC article.
151 results